Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation
Open Access
- 1 May 1998
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 18 (9) , 3251-3260
- https://doi.org/10.1523/jneurosci.18-09-03251.1998
Abstract
Inflammatory responses are a major component of secondary injury and play a central role in mediating the pathogenesis of acute and chronic spinal cord injury (SCI). The nuclear factor-κB (NF-κB) family of transcription factors is required for the transcriptional activation of a variety of genes regulating inflammatory, proliferative, and cell death responses of cells. In this study we examined the temporal and cellular expression of activated NF-κB after traumatic SCI. We used a contusion model (N.Y.U. Impactor) to initiate the early biochemical and molecular changes that occur after traumatic injury to reproduce the pathological events associated with acute inflammation after SCI. The activation and cellular distribution of activated NF-κB was evaluated by using a monoclonal antibody that selectively recognizes activated p65 in a NF-κB dimer. Immunohistochemical and Western blot analyses demonstrated that NF-κB activation occurred as early as 0.5 hr postinjury and persisted for at least 72 hr. Using electrophoretic mobility shift assays (EMSA), we demonstrate that NF-κB is activated after SCI. In our immunohistochemical, Western, and EMSA experiments there are detectable levels of activated NF-κB in our control animals. Using double-staining protocols, we detected activated NF-κB in macrophages/microglia, endothelial cells, and neurons within the injured spinal cord. Colocalization of activated NF-κB with the NF-κB-dependent gene product, inducible nitric oxide synthase (iNOS), suggests functional implications for this transcription factor in the pathogenesis of acute spinal cord injury. Although there is considerable evidence for the involvement of an inflammatory reaction after traumatic SCI, this is the first evidence for the activation of NF-κB after trauma. Strategies directed at blocking the initiation of this cascade may prove beneficial as a therapeutic approach for the treatment of acute SCI.Keywords
This publication has 50 references indexed in Scilit:
- Potential involvement of the transcription factor NF-κB in neurological disordersPublished by Elsevier ,2003
- Global Ischemia Activates Nuclear Factor-κB in Forebrain Neurons of RatsStroke, 1997
- Anti–Intercellular Adhesion Molecule–1 Antibody Reduces Ischemic Cell Damage After Transient But Not Permanent Middle Cerebral Artery Occlusion in the Wistar RatStroke, 1995
- Alteration of Transcription Factor Binding Activities in the Ischemic Rat-BrainBiochemical and Biophysical Research Communications, 1995
- Tumor Necrosis Factor-α-dependent Activation of a RelA Homodimer in AstrocytesPublished by Elsevier ,1995
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.Stroke, 1994
- Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasisNeuron, 1994
- Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons.Stroke, 1992
- Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment.Stroke, 1991